Stay Tuned-
I'll answer what I can. As you can tell from the poster's name, he was looking a recurrent cancer after IMRT failure (his treatment/PSA history is in his signature). His PSA rose above 2.0 over his nadir PSA, which is the signal for
biochemical recurrence after radiation. It was then confirmed as a
clinical failure by biopsy. (He probably also had a bone scan/CT to check for distant mets).
He said that 30% of his prostate was cryo-ablated. So this is focal (=less than whole gland), salvage ablation.
First of all, IMRT for low risk PC seldom fails - 95% have no recurrence (about
the same for surgery and other kinds of radiation). Sometimes when there is a large tumor, it gets protected by a low blood supply (called hypoxia) from radiation damage. Or it may have had stem cells or other genotype that was peculiarly radioresistant. I also don't know how many grays they used. IMRT these days is about
79-81 Gy, which is about
as high as you'd want it to prevent excess toxicity. (HDR brachy and SBRT use a nifty trick to get around that limit, and local failures seem to be lower.) That depends on having the right equipment to safely deliver doses like that. In a recent study of IMRT failures, about
half were local only, and therefore potentially amenable to salvage therapy.
Site of cancer recurrence after first-line (primary) radiation therapyThe catheter protects the urethra during treatment and helps prevent strictures. A lot depends on where the focal treatment is. The catheter allows the urethra to heal without swelling shut. Some focal treatments are ruled out entirely if they are too close to the urethra, bladder neck, or rectum. Heat (or cold) travels and can do damage outside of the treatment zone. That's true of all forms of thermal ablation (e.g., laser, HIFU, cryo, PDT, RF).